TECTONIC THERAPEUTIC, INC. Finance Lease, Right-of-Use Asset, Amortization
TECTONIC THERAPEUTIC, INC. (TECX) reported Finance Lease, Right-of-Use Asset, Amortization of $78.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $78.00K, a 26.42% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $85.00K, a 19.81% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $106.00K, a 7.83% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $106.00K.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $424.00K, a 5.36% decline from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $448.00K, a 8.20% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $488.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|
| 2026-06-30 | $78.00K 10-Q · filed 2026-08-06 | $163.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $85.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $424.00K 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $106.00K 10-Q · filed 2026-08-06 | $212.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $106.00K 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $448.00K 10-K · filed 2026-02-26 | ||
| 2024-06-30 | $115.00K 10-Q · filed 2024-08-14 | $230.00K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $488.00K 10-K · filed 2025-03-20 | ||
| 2023-06-30 | $124.00K 10-Q · filed 2024-08-14 | $258.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |